Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Breast-conserving therapy in older patients with breast cancer over three decades: progress or stagnation.

Jobsen JJ, Middelburg JG, van der Palen J, Riemersma S, Siemerink E, Struikmans H, Siesling S.

J Geriatr Oncol. 2018 Aug 18. pii: S1879-4068(18)30123-1. doi: 10.1016/j.jgo.2018.08.007. [Epub ahead of print]

PMID:
30131236
2.

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

van der Wekken AJ, Pelgrim R, 't Hart N, Werner N, Mastik MF, Hendriks L, van der Heijden EHFM, Looijen-Salamon M, de Langen AJ, Staal-van den Brekel J, Riemersma S, van den Borne BE, Speel EJM, Dingemans AC, Hiltermann TJN, van den Berg A, Timens W, Schuuring E, Groen HJM.

Clin Cancer Res. 2017 Aug 1;23(15):4251-4258. doi: 10.1158/1078-0432.CCR-16-1631. Epub 2017 Feb 9.

3.

Bilateral breast cancer, synchronous and metachronous; differences and outcome.

Jobsen JJ, van der Palen J, Ong F, Riemersma S, Struikmans H.

Breast Cancer Res Treat. 2015 Sep;153(2):277-83. doi: 10.1007/s10549-015-3538-5. Epub 2015 Aug 13.

PMID:
26268697
4.

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach.

Dekker TJ, ter Borg S, Hooijer GK, Meijer SL, Wesseling J, Boers JE, Schuuring E, Bart J, van Gorp J, Bult P, Riemersma SA, van Deurzen CH, Sleddens HF, Mesker WE, Kroep JR, Smit VT, van de Vijver MJ.

Breast Cancer Res Treat. 2015 Jul;152(2):253. doi: 10.1007/s10549-015-3478-0. No abstract available.

5.

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach.

Dekker TJ, ter Borg S, Hooijer GK, Meijer SL, Wesseling J, Boers JE, Schuuring E, Bart J, van Gorp J, Bult P, Riemersma SA, van Deurzen CH, Sleddens HF, Mesker WE, Kroep JR, Smit VT, van de Vijver MJ.

Breast Cancer Res Treat. 2015 Jul;152(2):247-52. doi: 10.1007/s10549-015-3444-x. Epub 2015 Jun 4. Erratum in: Breast Cancer Res Treat. 2015 Jul;152(2):253.

6.

Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy.

Jobsen J, van der Palen J, Riemersma S, Heijmans H, Ong F, Struikmans H.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1006-1014. doi: 10.1016/j.ijrobp.2014.04.039. Epub 2014 Jul 8.

PMID:
25035203
7.

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

Knijn N, Mekenkamp LJ, Klomp M, Vink-Börger ME, Tol J, Teerenstra S, Meijer JW, Tebar M, Riemersma S, van Krieken JH, Punt CJ, Nagtegaal ID.

Br J Cancer. 2011 Mar 15;104(6):1020-6. doi: 10.1038/bjc.2011.26. Epub 2011 Mar 1.

8.

Vaginal and (uncommon) cervical cancers in the Netherlands, 1989-2003.

van der Aa MA, Helmerhorst TJ, Siesling S, Riemersma S, Coebergh JW.

Int J Gynecol Cancer. 2010 May;20(4):638-45. doi: 10.1111/IGC.0b013e3181a44f4.

PMID:
20686385
9.

The impact of margin status in breast-conserving therapy for lobular carcinoma is age related.

Jobsen JJ, Riemersma S, van der Palen J, Ong F, Jonkman A, Struikmans H.

Eur J Surg Oncol. 2010 Feb;36(2):176-81. doi: 10.1016/j.ejso.2009.06.003. Epub 2009 Jul 31.

PMID:
19647390
10.

The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.

Riemersma SA, Jordanova ES, Haasnoot GW, Drabbels J, Schuuring E, Schreuder GM, Kluin PM.

Hum Immunol. 2006 Apr-May;67(4-5):303-10. Epub 2006 Apr 7.

PMID:
16720210
11.

Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma.

Booman M, Douwes J, Glas AM, Riemersma SA, Jordanova ES, Kok K, Rosenwald A, de Jong D, Schuuring E, Kluin PM.

Clin Cancer Res. 2006 May 1;12(9):2698-705.

12.

High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.

Riemersma SA, Oudejans JJ, Vonk MJ, Dreef EJ, Prins FA, Jansen PM, Vermeer MH, Blok P, Kibbelaar RE, Muris JJ, Schuuring EM, Kluin PM.

J Pathol. 2005 Jul;206(3):328-36.

PMID:
15887291
13.

Flow cytometric sorting of paraffin-embedded tumor tissues considerably improves molecular genetic analysis.

Jordanova ES, Corver WE, Vonk MJ, Leers MP, Riemersma SA, Schuuring E, Kluin PM.

Am J Clin Pathol. 2003 Sep;120(3):327-34.

PMID:
14502796
14.

Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.

Jordanova ES, Riemersma SA, Philippo K, Schuuring E, Kluin PM.

Int J Cancer. 2003 Jan 20;103(3):393-8.

15.

Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.

Jordanova ES, Riemersma SA, Philippo K, Giphart-Gassler M, Schuuring E, Kluin PM.

Genes Chromosomes Cancer. 2002 Sep;35(1):38-48.

PMID:
12203788
16.

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.

Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E, Kluin PM.

Blood. 2000 Nov 15;96(10):3569-77.

17.

Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita.

Vincent A, Jacobson L, Plested P, Polizzi A, Tang T, Riemersma S, Newland C, Ghorazian S, Farrar J, MacLennan C, Willcox N, Beeson D, Newsom-Davis J.

Ann N Y Acad Sci. 1998 May 13;841:482-96. Review.

PMID:
9668280
18.

Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspects.

Hoedemaekers AC, Verschuuren JJ, Spaans F, Graus YF, Riemersma S, van Breda Vriesman PJ, De Baets MH.

Muscle Nerve. 1997 Sep;20(9):1091-101.

PMID:
9270663
19.

Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function.

Riemersma S, Vincent A, Beeson D, Newland C, Hawke S, Vernet-der Garabedian B, Eymard B, Newsom-Davis J.

J Clin Invest. 1996 Nov 15;98(10):2358-63.

20.

Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen.

Vincent A, Newland C, Brueton L, Beeson D, Riemersma S, Huson SM, Newsom-Davis J.

Lancet. 1995 Jul 1;346(8966):24-5.

PMID:
7603140
21.

Leptoproduction of heavy quarks in the fixed and variable flavor schemes.

Olness FI, Riemersma ST.

Phys Rev D Part Fields. 1995 May 1;51(9):4746-4755. No abstract available.

PMID:
10018951
22.

Complete next-to-leading order QCD corrections to the photon structure functions F2 gamma (x,Q2) and FL gamma (x,Q2).

Laenen E, Riemersma S, Smith J, van Neerven WL.

Phys Rev D Part Fields. 1994 Jun 1;49(11):5753-5768. No abstract available.

PMID:
10016900

Supplemental Content

Loading ...
Support Center